BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals 2025, 18, 185.

This review article examined BPC 157, a synthetic peptide, and its proposed mechanisms of action related to angiogenesis and nitric oxide regulation in protecting against cellular damage while maintaining protective functions. The authors discuss BPC 157’s multifunctional properties and potential medical applications based on existing literature and patent data, suggesting the peptide may modulate harmful versus beneficial effects of nitric oxide and angiogenesis. The evidence presented is from a literature and patent review (evidence level: review article).

Read more on Pharmaceuticals (Basel, Switzerland) →

Scroll to Top